Cargando…

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT

BACKGROUND: Mesolimbic and nigrostriatal dopaminergic pathways play important roles in both the rewarding and conditioning effects of drugs. The dopamine transporter (DAT) is of central importance in regulating dopaminergic neurotransmission and in particular in activating the striatal D(2)-like rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomsen, Gerda, Knudsen, Gitte Moos, Jensen, Peter S, Ziebell, Morten, Holst, Klaus K, Asenbaum, Susanne, Booij, Jan, Darcourt, Jacques, Dickson, John C, Kapucu, Özlem L, Nobili, Flavio, Sabri, Osama, Sera, Terez, Tatsch, Klaus, Tossici-Bolt, Livia, Laere, Koen Van, Borght, Thierry Vander, Varrone, Andrea, Pagani, Marco, Pinborg, Lars Hageman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671201/
https://www.ncbi.nlm.nih.gov/pubmed/23688063
http://dx.doi.org/10.1186/2191-219X-3-39
_version_ 1782271945152135168
author Thomsen, Gerda
Knudsen, Gitte Moos
Jensen, Peter S
Ziebell, Morten
Holst, Klaus K
Asenbaum, Susanne
Booij, Jan
Darcourt, Jacques
Dickson, John C
Kapucu, Özlem L
Nobili, Flavio
Sabri, Osama
Sera, Terez
Tatsch, Klaus
Tossici-Bolt, Livia
Laere, Koen Van
Borght, Thierry Vander
Varrone, Andrea
Pagani, Marco
Pinborg, Lars Hageman
author_facet Thomsen, Gerda
Knudsen, Gitte Moos
Jensen, Peter S
Ziebell, Morten
Holst, Klaus K
Asenbaum, Susanne
Booij, Jan
Darcourt, Jacques
Dickson, John C
Kapucu, Özlem L
Nobili, Flavio
Sabri, Osama
Sera, Terez
Tatsch, Klaus
Tossici-Bolt, Livia
Laere, Koen Van
Borght, Thierry Vander
Varrone, Andrea
Pagani, Marco
Pinborg, Lars Hageman
author_sort Thomsen, Gerda
collection PubMed
description BACKGROUND: Mesolimbic and nigrostriatal dopaminergic pathways play important roles in both the rewarding and conditioning effects of drugs. The dopamine transporter (DAT) is of central importance in regulating dopaminergic neurotransmission and in particular in activating the striatal D(2)-like receptors. Molecular imaging studies of the relationship between DAT availability/dopamine synthesis capacity and active cigarette smoking have shown conflicting results. Through the collaboration between 13 SPECT centres located in 10 different European countries, a database of FP-CIT-binding in healthy controls was established. We used the database to test the hypothesis that striatal DAT availability is changed in active smokers compared to non-smokers and ex-smokers. METHODS: A total of 129 healthy volunteers were included. Subjects were divided into three categories according to past and present tobacco smoking: (1) non-smokers (n = 64), (2) ex-smokers (n = 39) and (3) active smokers (n = 26). For imaging of the DAT availability, we used [(123)I]FP-CIT (DaTSCAN) and single photon emission computed tomography (SPECT). Data were collected in collaboration between 13 SPECT centres located in 10 different European countries. The striatal measure of DAT availability was analyzed in a multiple regression model with age, SPECT centre and smoking as predictor. RESULTS: There was no statistically significant difference in DAT availability between the groups of active smokers, ex-smokers and non-smokers (p = 0.34). Further, we could not demonstrate a significant association between striatal DAT and the number of cigarettes per day or total lifetime cigarette packages in smokers and ex-smokers. CONCLUSION: Our results do not support the hypothesis that large differences in striatal DAT availability are present in smokers compared to ex-smokers and healthy volunteers with no history of smoking.
format Online
Article
Text
id pubmed-3671201
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-36712012013-06-06 No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT Thomsen, Gerda Knudsen, Gitte Moos Jensen, Peter S Ziebell, Morten Holst, Klaus K Asenbaum, Susanne Booij, Jan Darcourt, Jacques Dickson, John C Kapucu, Özlem L Nobili, Flavio Sabri, Osama Sera, Terez Tatsch, Klaus Tossici-Bolt, Livia Laere, Koen Van Borght, Thierry Vander Varrone, Andrea Pagani, Marco Pinborg, Lars Hageman EJNMMI Res Original Research BACKGROUND: Mesolimbic and nigrostriatal dopaminergic pathways play important roles in both the rewarding and conditioning effects of drugs. The dopamine transporter (DAT) is of central importance in regulating dopaminergic neurotransmission and in particular in activating the striatal D(2)-like receptors. Molecular imaging studies of the relationship between DAT availability/dopamine synthesis capacity and active cigarette smoking have shown conflicting results. Through the collaboration between 13 SPECT centres located in 10 different European countries, a database of FP-CIT-binding in healthy controls was established. We used the database to test the hypothesis that striatal DAT availability is changed in active smokers compared to non-smokers and ex-smokers. METHODS: A total of 129 healthy volunteers were included. Subjects were divided into three categories according to past and present tobacco smoking: (1) non-smokers (n = 64), (2) ex-smokers (n = 39) and (3) active smokers (n = 26). For imaging of the DAT availability, we used [(123)I]FP-CIT (DaTSCAN) and single photon emission computed tomography (SPECT). Data were collected in collaboration between 13 SPECT centres located in 10 different European countries. The striatal measure of DAT availability was analyzed in a multiple regression model with age, SPECT centre and smoking as predictor. RESULTS: There was no statistically significant difference in DAT availability between the groups of active smokers, ex-smokers and non-smokers (p = 0.34). Further, we could not demonstrate a significant association between striatal DAT and the number of cigarettes per day or total lifetime cigarette packages in smokers and ex-smokers. CONCLUSION: Our results do not support the hypothesis that large differences in striatal DAT availability are present in smokers compared to ex-smokers and healthy volunteers with no history of smoking. Springer 2013-05-20 /pmc/articles/PMC3671201/ /pubmed/23688063 http://dx.doi.org/10.1186/2191-219X-3-39 Text en Copyright ©2013 Thomsen et al.; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Thomsen, Gerda
Knudsen, Gitte Moos
Jensen, Peter S
Ziebell, Morten
Holst, Klaus K
Asenbaum, Susanne
Booij, Jan
Darcourt, Jacques
Dickson, John C
Kapucu, Özlem L
Nobili, Flavio
Sabri, Osama
Sera, Terez
Tatsch, Klaus
Tossici-Bolt, Livia
Laere, Koen Van
Borght, Thierry Vander
Varrone, Andrea
Pagani, Marco
Pinborg, Lars Hageman
No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
title No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
title_full No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
title_fullStr No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
title_full_unstemmed No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
title_short No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
title_sort no difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)i]fp-cit (datscan) and spect
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671201/
https://www.ncbi.nlm.nih.gov/pubmed/23688063
http://dx.doi.org/10.1186/2191-219X-3-39
work_keys_str_mv AT thomsengerda nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT knudsengittemoos nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT jensenpeters nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT ziebellmorten nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT holstklausk nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT asenbaumsusanne nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT booijjan nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT darcourtjacques nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT dicksonjohnc nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT kapucuozleml nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT nobiliflavio nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT sabriosama nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT seraterez nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT tatschklaus nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT tossiciboltlivia nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT laerekoenvan nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT borghtthierryvander nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT varroneandrea nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT paganimarco nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect
AT pinborglarshageman nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect